about
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer developmentZNF703 gene amplification at 8p12 specifies luminal B breast cancerRegulation of the transcription factor FOXM1c by Cyclin E/CDK2A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapyIntegrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancerp27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on preclinical and translational researchIdentification of a three-gene expression signature of poor-prognosis breast carcinomaPrognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray dataLow-molecular-weight cyclin E: the missing link between biology and clinical outcomeGenomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerNovel Molecular Markers for Breast CancerOncolytic Replication of E1b-Deleted AdenovirusesCIViC databaseBrk is coamplified with ErbB2 to promote proliferation in breast cancerMMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancerCyclin D1: polymorphism, aberrant splicing and cancer riskSperm associated antigen 9 plays an important role in bladder transitional cell carcinomaMolecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin ECyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1).A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data.Analysis of cyclins A, B1, D1 and E in breast cancer in relation to tumour grade and other prognostic factorsLow-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.siRNA-based targeting of cyclin E overexpression inhibits breast cancer cell growth and suppresses tumor development in breast cancer mouse model.PP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancer.Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplificationA novel interaction between HER2/neu and cyclin E in breast cancer.DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instabilityThe neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer.Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patientsToo much cleavage of cyclin E promotes breast tumorigenesis.ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.An intron-retaining splice variant of human cyclin A2, expressed in adult differentiated tissues, induces a G1/S cell cycle arrest in vitro.ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells.Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma
P2860
Q22000752-F85B2032-06AF-40DF-994D-3B9DF60A46E9Q24293333-0E4935F5-BED0-4E66-B38D-27380FEF9187Q24305960-AAA73E4C-3AC5-416F-A896-B17123F00332Q24538802-03787FA7-BFC8-459F-9512-FA1BC7E401E0Q24633201-9AECCB12-BD5F-4500-8BA3-C7381EB8BACDQ24650994-9B66BBB7-6C7E-427B-9D34-1FC27DC811E8Q24794378-4CA9F4E0-F5E8-4397-A14D-D50AA2FAF3A9Q24802692-1686DBE9-EAB9-46A8-8F73-1F3ABEECBECBQ24804050-3922DA7F-5C34-43F0-9B47-37761E74F450Q24806316-45E5905B-81A5-4C28-A4AB-B64BD90C39EBQ26738987-C58CBF1E-C986-4F8F-BD58-CED9D271189DQ26753160-7794D5E0-01CB-474E-B07D-C885D6FB21FCQ26777406-875636DE-2D56-4102-9916-F59371D8064DQ27612411-BE1533CF-967F-40FE-B31A-C59A719CF6AAQ28115616-F2D67232-623A-4B53-A49B-38B23F33763CQ28250940-361481C8-585E-4454-98CC-DC05CB78E399Q28303053-EA4EA468-0829-4A77-83A0-32B9EFA38B37Q28304265-47D22EEA-8B12-4FE6-8C49-9240D478F765Q28486255-22B0F77C-FD70-4FBB-A7D8-5EC9DA9CCE9FQ30480596-6B779DB6-604A-4EAF-B9BC-7C59E7A493B8Q33165699-4D45C2BA-61C7-40F3-ACB6-163B0AE5B552Q33368855-9124ED2C-662F-443E-A3D0-23DB019E8CB1Q33483633-152AC9D6-CA48-4ED8-A9A5-6475C672C4E2Q33658276-8912517D-7815-44D5-B613-336462F115C0Q33705021-1C00A77D-E5C2-4174-9088-85BD63C86222Q33782728-836281E7-F014-4ABD-82BD-AA78A1A6D85AQ33890172-5ACE5B41-F946-4C4C-B6D0-9239852C6FA2Q33903965-6FFD8467-F6EC-4A91-BADB-A052A41D9B2CQ33925994-6CC80192-B1A4-468E-8F91-8D561EC458ADQ33976264-584A2553-8529-45B5-81B4-C483E995C855Q34067829-D81F9B3D-606F-4977-91E5-9A413034DEC0Q34134278-4C30FA8A-EC41-4F20-B2E3-DF7DC7304AC1Q34157822-9654E5C0-CCA4-48BB-97FB-183ECEF820E9Q34220979-44567032-CFB1-438F-A415-ADC3E8FA38AEQ34221065-165AC686-C046-447A-BF5D-0837804FC7BEQ34252194-44544EB4-3E41-4811-80ED-5464668A9496Q34321288-E52B3BBA-3487-4746-A211-FF69249B59B5Q34345868-73331F92-67D0-413B-84A4-6D62C71A41FAQ34350229-63F376BB-4BDF-4D79-866F-5BDA9F038888Q34390176-3A0D81EB-1D7B-4B96-8EC4-0927A84B4655
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cyclin E and survival in patients with breast cancer.
@ast
Cyclin E and survival in patients with breast cancer.
@en
Cyclin E and survival in patients with breast cancer.
@nl
type
label
Cyclin E and survival in patients with breast cancer.
@ast
Cyclin E and survival in patients with breast cancer.
@en
Cyclin E and survival in patients with breast cancer.
@nl
prefLabel
Cyclin E and survival in patients with breast cancer.
@ast
Cyclin E and survival in patients with breast cancer.
@en
Cyclin E and survival in patients with breast cancer.
@nl
P2093
P3181
P356
P1476
Cyclin E and survival in patients with breast cancer.
@en
P2093
Christopher Knickerbocker
Gabriel N Hortobagyi
Isabelle Bedrosian
Khandan Keyomarsi
Matthew Callister
Michael Lowe
Sarah S Bacus
Susan L Tucker
Thaddeus W Herliczek
Thomas A Buchholz
P304
P3181
P356
10.1056/NEJMOA021153
P407
P577
2002-11-14T00:00:00Z